%PDF-1.4
%
64 0 obj
<>
endobj
61 0 obj
<>
endobj
147 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2004-05-11T17:01:39Z
2024-03-29T03:53:29-07:00
QuarkXPressª 4.11: AdobePS 8.8.0 (301)
2024-03-29T03:53:29-07:00
application/pdf
Heather
2003-271.june
uuid:ebd3a643-1dd1-11b2-0a00-180927bd7200
uuid:ebd3a645-1dd1-11b2-0a00-880000000000
endstream
endobj
50 0 obj
<>
endobj
51 0 obj
<>
endobj
65 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 30 0 R/Type/Page>>
endobj
1 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 32 0 R/Type/Page>>
endobj
4 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 34 0 R/Type/Page>>
endobj
7 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 36 0 R/Type/Page>>
endobj
10 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 38 0 R/Type/Page>>
endobj
13 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 40 0 R/Type/Page>>
endobj
16 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 42 0 R/Type/Page>>
endobj
19 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 44 0 R/Type/Page>>
endobj
178 0 obj
[182 0 R]
endobj
179 0 obj
<>stream
q
0 0 612 792 re
W n
BT
0.85091 0.85091 0.85091 rg
/T1_0 19 Tf
0.6303 0.7762 -0.7762 0.6303 16.7778 46.0632 Tm
(Personal non-commercial use only. The Journal of Rheumatology. Copyright\
\251 2004. All rights reserved)Tj
ET
Q
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 614 -794 re
W n
q
0 792.03 612 -792 re
W n
BT
0 0 0 1 k
/GS1 gs
/T1_1 1 Tf
-0.00011 Tc 0.0193 Tw 10 0 0 10 54 713.1616 Tm
(\(b\) Straight leg raise \(SLR\) to an approximate angle of 45\241.)Tj
0.2001 Tw 0 -1.2 TD
(\(c\) Short arc quadriceps contraction. \(d\) Isotonic quadri-)Tj
0.00681 Tc 0.3681 Tw T*
[(ceps contraction in sitting from 90\241)-625 (to zero degrees. )]TJ
-0.00011 Tc 0.1051 Tw T*
(\(e\) Hamstring contraction in sitting using tubing for resis-)Tj
0.189 Tw T*
[(tance. D. Cool-down: )54.9 (Apply an ice pack to the involved)]TJ
0.09669 Tw T*
(knee for 15 to 20 minutes, with the knee in a comfortable)Tj
0 Tw T*
(position.)Tj
/T1_2 1 Tf
0 -2.4 TD
(REFERENCES)Tj
/T1_1 1 Tf
0.02499 Tw 8 0 0 8 61 607.1616 Tm
[(1.)-875.1 (Heck DA, Robinson RL, Partridge CM, Lubitz RM, Freund DA.)]TJ
1.675 -1.25 Td
(Patient outcomes after knee replacement. Clin Orthop Rel Res)Tj
0 Tc 0 Tw 0 -1.25 TD
[(1998;356:93-1)36.9 (10.)]TJ
-0.00011 Tc 0.02499 Tw -1.675 -1.25 Td
[(2.)-875.1 (Norman-T)69.7 (aylor FH, Palmer CR, )17.7 (V)59.8 (illar RN. Quality-of-life )]TJ
1.675 -1.25 Td
(improvement compared after hip and knee replacement. J Bone)Tj
0 Tc T*
[(Joint Sur)17.8 (g Br 1996;78:74-7.)]TJ
-0.00011 Tc -1.675 -1.25 Td
[(3.)-875.1 (Jones CA, )17.7 (V)128.9 (oaklander DC, Johnston DW)91.7 (, Suarez-Almazor ME.)]TJ
1.675 -1.25 Td
(Health related quality of life outcomes after total hip and knee)Tj
T*
(arthroplasties in a community based population. J Rheumatol)Tj
0 Tc 0 Tw T*
(2000;27:1745-52.)Tj
-0.00011 Tc 0.02499 Tw -1.675 -1.25 Td
[(4.)-875.1 (W)39.8 (inter SV)128.8 (, Burch D, )17.7 (W)79.9 (eidenhielm L, Mattsson E, Brostrom L,)]TJ
1.675 -1.25 Td
[(W)79.9 (ersall-Robertsson E. Ef)17.7 (fects of preoperative water exercise on)]TJ
T*
[(total knee replacement patients. J )54.8 (Aquatic Phys )17.7 (Ther 2000;8:12-7.)]TJ
-1.675 -1.25 Td
[(5.)-875.1 (Rodgers JA, Garvin KL, )17.7 (W)79.9 (alker CW)91.7 (, Morford D, Urban J, Bedard)]TJ
1.675 -1.25 Td
[(J. Preoperative physical therapy in primary total knee arthroplasty)64.8 (.)]TJ
-0.0298 Tw T*
[(J Arthroplasty )-54.8 (1998;13:414-21.)]TJ
0.02499 Tw -1.675 -1.25 Td
[(6.)-875.1 (D\325Lima DD, Colwell CW)91.7 (, Morris BA, Hardwick ME, Kozin F)79.7 (.)-0.1 ( )17.7 (The)]TJ
1.675 -1.25 Td
[(ef)17.7 (fect of preoperative exercise on total knee replacement outcomes.)]TJ
T*
(Clin Orthop Rel Res 1996;326:174-82.)Tj
-1.675 -1.25 Td
[(7.)-875.1 (Roach JA, )17.7 (T)35 (remblay LM, Bowers DL. )54.8 (A)-220.1 (preoperative assessment)]TJ
1.675 -1.25 Td
(and education program: implementation and outcomes. Patient)Tj
0 Tc T*
(Educ Couns 1995;25:83-8.)Tj
-0.00011 Tc -1.675 -1.25 Td
[(8.)-875.1 (Hughes K, Kuf)17.7 (fner L, Dean B. Ef)17.7 (fect of weekend physical therapy)]TJ
1.675 -1.25 Td
(treatment on postoperative length of stay following total hip and)Tj
0 Tc T*
[(total knee arthroplasty)64.9 (. Phys Can 1993;45:245-9.)]TJ
-0.00011 Tc -1.675 -1.25 Td
[(9.)-875.1 (Moller G, Jonsson E. Hospital care versus home care for )]TJ
1.675 -1.25 Td
[(rehabilitation after hip rehabilitation. Int J )17.7 (T)69.9 (echnol )54.8 (Assess)]TJ
T*
(Healthcare 1992;8:93-101.)Tj
-2.175 -1.25 Td
[(10.)-875.1 (Shoji H, Solomonow M, )36.8 (Y)99.8 (oshino S, D\325Ambrosia R, Dabezies E.)]TJ
2.175 -1.25 Td
[(Factors af)17.7 (fecting postoperative flexion in total knee arthroplasty)64.8 (.)]TJ
T*
(Orthopedics 1990;13:643-9.)Tj
-2.1381 -1.25 Td
[(1)36.8 (1)-0.1 (.)-875.1 (Kovar P)91.7 (A, )54.8 (Allegrante JP)110.7 (, MacKenzie CR, Peterson MG, Gutin B,)]TJ
2.1381 -1.25 Td
(Charlson ME. Supervised fitness walking in patients with)Tj
T*
[(osteoarthritis of the knee. )54.8 (A)-220.1 (randomized, controlled trial. )54.8 (Ann Intern)]TJ
0 Tc T*
[(Med 1992;1)36.9 (16:529-34.)]TJ
-0.00011 Tc -2.175 -1.25 Td
[(12.)-875.1 (Marks R. )17.7 (The ef)17.7 (fect of isometric quadriceps strength training in)]TJ
2.175 -1.25 Td
[(mid-range for osteoarthritis of the knee. )54.8 (Arthritis Rheum)]TJ
0 Tw T*
(1993;6:52-6.)Tj
0.02499 Tw -2.175 -1.25 Td
[(13.)-875.1 (Dexter P)91.7 (A. Joint exercises in elderly persons with symptomatic)]TJ
2.175 -1.25 Td
(osteoarthritis of the hip or knee. Performance patterns, medical)Tj
T*
(support patterns, and the relationship between exercising and)Tj
T*
[(medical care. )54.8 (Arthritis Rheum 1992;5:36-41.)]TJ
-2.175 -1.25 Td
[(14.)-875.1 (Schwartz-Barcott D, Fortin J, Kim H. Client-nurse interaction:)]TJ
2.175 -1.25 Td
(testing for its impact in preoperative instruction. Int J Nurs Studies)Tj
0 Tc 0 Tw T*
(1994;31:23-35.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(15.)-875.1 (W)79.9 (ong J, )17.7 (W)79.9 (ong S, Nolde )17.7 (T)74 (,)-0.1 ( )36.8 (Y)99.8 (absley R. Ef)17.7 (fects of an experimental)]TJ
2.175 -1.25 Td
[(program on post-hospital adjustment of early dischar)17.7 (ged patients.)]TJ
T*
(Int J Nurs Studies 1990;27:7-20.)Tj
-2.175 -1.25 Td
[(16.)-875.1 (Santavirta N, Lilliquist G, Sarvimaki )54.8 (A, Honkanen )17.7 (V)128.9 (, Konttinen )36.8 (Y)128.9 (,)]TJ
2.175 -1.25 Td
[(Santavirta S. )17.7 (T)69.9 (eaching of patients under)17.7 (going total hip replacement)]TJ
T*
[(sur)17.7 (gery)64.8 (. Int J Nurs Studies 1994;31:135-42.)]TJ
-2.175 -1.25 Td
[(17.)-875.1 (Bombardier C, Melfi CA, Paul J, et al. Comparison of a generic)]TJ
2.175 -1.25 Td
(and a disease-specific measure of pain and physical function after)Tj
T*
[(knee replacement sur)17.7 (gery)64.8 (. Med Care 1995;33 Suppl:AS131-44.)]TJ
30.825 79.671 Td
[(18.)-875.1 (Barr S, Bellamy N, Buchanan )17.7 (WW)91.7 (, et al. )54.8 (A)-220.1 (comparative study of)]TJ
2.175 -1.25 Td
(signal versus aggregate methods of outcome measurement based on)Tj
T*
[(the )17.7 (WOMAC Osteoarthritis Index. J Rheumatol 1994;21:2106-12.)]TJ
-2.175 -1.25 Td
[(19.)-875.1 (Stucki G, Sangha O, Stucki S, et al. Comparison of the )17.7 (WOMAC)]TJ
2.175 -1.25 Td
[(\(W)79.7 (estern Ontario and McMaster Universities\) osteoarthritis index)]TJ
T*
(and a self-report format of the self-administered )Tj
T*
(Lequesne-Algofunctional index in patients with knee and hip)Tj
T*
(osteoarthritis. Osteoarthritis Cartilage 1998;6:79-86.)Tj
-2.175 -1.25 Td
[(20.)-875.1 (Bellamy N, Buchanan )17.7 (WW)91.7 (, Goldsmith CH, Campbell J, Stitt L)73.9 (W)91.8 (.)]TJ
2.175 -1.25 Td
[(V)110.8 (alidation study of )17.7 (WOMAC: a health status instrument for)]TJ
T*
(measuring clinically important patient relevant outcomes to)Tj
T*
(antirheumatic drug therapy in patients with osteoarthritis of the hip)Tj
T*
(or knee. J Rheumatol 1988;15:1833-40.)Tj
-2.175 -1.25 Td
[(21.)-875.1 (Bellamy N. Critical review of clinical assessment techniques for)]TJ
2.175 -1.25 Td
(rheumatoid arthritis trials: new developments. Scand J Rheumatol)Tj
0 Tc T*
(1989;80 Suppl:3-16.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(22.)-875.1 (Enwemeka CS. Radiographic verification of knee goniometry)64.8 (. )]TJ
2.175 -1.25 Td
[(J )54.8 (Aquatic Phys )17.7 (Ther 1986;18:47-9.)]TJ
-2.175 -1.25 Td
[(23.)-875.1 (Gogia PP)110.8 (, Braatz JH, Rose SJ, Norton BJ. Reliability and validity)]TJ
2.175 -1.25 Td
[(of goniometric measurements at the knee. Phys )17.7 (Ther )]TJ
0 Tc 0 Tw T*
(1987;49:465-9.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(24.)-875.1 (Hayes KW)91.7 (, Falconer J. Reliability of hand-held dynamometry and)]TJ
2.175 -1.25 Td
(its relationship with manual muscle testing in patients with)Tj
T*
[(osteoarthritis of the knee. J Orthop Sports Phys )17.7 (Ther )]TJ
0 Tc 0 Tw T*
(1992;16:145-9.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(25.)-875.1 (Daniels L, )17.7 (W)79.9 (orthingham C. Muscle testing: techniques of manual)]TJ
2.175 -1.25 Td
(examination. 3rd ed. Philadelphia: Saunders; 1972:57-61.)Tj
-2.175 -1.25 Td
[(26.)-875.1 (Hawker G, Melfi C, Paul J, Green R, Bombardier C. Comparison of)]TJ
2.175 -1.25 Td
[(a generic \(SF-36\) and a disease specific \(WOMAC\) \(W)79.7 (estern)]TJ
T*
(Ontario and McMaster Universities Osteoarthritis Index\) instrument)Tj
T*
[(in the measurement of outcomes after knee replacement sur)17.7 (gery)64.9 (. )]TJ
T*
[(J Rheumatol 1995;22:1)36.8 (193-6.)]TJ
-2.175 -1.25 Td
[(27.)-875.1 (Hayes )17.7 (V)128.9 (, Morris J, )17.7 (W)79.9 (olfe C, Mor)17.7 (gan M. )17.7 (The SF-36 health survey)]TJ
2.175 -1.25 Td
[(questionnaire: is it suitable for use with older adults? )54.8 (Age )54.9 (Ageing)]TJ
0 Tc 0 Tw T*
(1995;24:120-5.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(28.)-875.1 (Stucki G, Liang MH, Phillips C, Katz JN. )17.7 (The Short Form-36 is)]TJ
2.175 -1.25 Td
[(preferable to the SIP)-238.2 (as a generic health status measure in patients)]TJ
T*
[(under)17.7 (going elective total hip arthroplasty)64.8 (. )54.8 (Arthritis Rheum)]TJ
0 Tc 0 Tw T*
(1995;8:174-81.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(29.)-875.1 (Parker SG, Peet SM, Jagger C, Farhan M, Castleden CM.)]TJ
2.175 -1.25 Td
[(Measuring health status in older patients. )17.7 (The SF-36 in practice.)]TJ
-0.0298 Tw T*
[(Age Ageing )-54.9 (1998;27:13-8.)]TJ
0.02499 Tw -2.175 -1.25 Td
[(30.)-875.1 (L)55 (yons RA, Fielder H, Littlepage BN. Measuring health status with)]TJ
2.175 -1.25 Td
(the SF-36: the need for regional norms. J Pub Health Med)Tj
0 Tc 0 Tw T*
(1995;17:46-50.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(31.)-875.1 (Drummond MF)79.7 (, O\325Brien B, Stoddart G, )17.7 (T)69.9 (orrence G. Basic types of)]TJ
2.175 -1.25 Td
(economic evaluation in methods for the evaluation of health care)Tj
T*
(programmes. 2nd ed. Oxford: Oxford University Press; 1997.)Tj
-2.175 -1.25 Td
[(32.)-875.1 (Beaupre LA, Davies DM, Jones CA, Cinats JG. Exercise combined)]TJ
2.175 -1.25 Td
(with continuous passive motion or slider board therapy compared)Tj
T*
(with exercise only: a randomized controlled trial of patients)Tj
T*
[(following total knee arthroplasty)64.8 (. Phys )17.7 (Ther 2001;81:1029-37.)]TJ
-2.175 -1.25 Td
[(33.)-875.1 (L)55 (ydick E, Epstein RS. Interpretation of quality of life changes. Qual)]TJ
2.175 -1.25 Td
(Life Res 1993;2:221-6.)Tj
-2.175 -1.25 Td
[(34.)-875.1 (Cohen J. Statistical power analysis for the behavioral sciences. New)]TJ
2.175 -1.25 Td
[(Y)99.8 (ork: )54.8 (Academic Press; 1977:8.)]TJ
-2.175 -1.25 Td
[(35.)-875.1 (Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the)]TJ
2.175 -1.25 Td
(significance of change in health-related quality of life scores. J Clin)Tj
0 Tc T*
(Oncol 1998;16:136-44.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(36.)-875.1 (Curran DL, Fayers P)110.7 (, Molenber)17.7 (ghs G, Machin D. )54.8 (Analysis of)]TJ
2.175 -1.25 Td
(incomplete quality of life data in clinical trials. In: Staquet MJ,)Tj
T*
(Hays RD, Fayers PM, editors. Quality of life assessment in clinical)Tj
T*
(trials: methods and practice. Oxford: Oxford University Press;)Tj
0 Tc 0 Tw T*
(1998:250-80.)Tj
ET
0 0 0 1 K
54 54 m
558 54 l
S
BT
/T1_3 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 54.5 35.9844 Tm
[(Beaupr)36.8 (e, et al: Exer)36.8 (cise and TKA)]TJ
0 Tc 0 Tw 60.9375 -0.0313 Td
(1173)Tj
ET
0 0 0 0 k
/GS0 gs
109.22 59.08 396.48 -10.83 re
f*
0.5 w
109.22 59.08 396.48 -10.83 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 0 0 rg
/GS2 gs
/T1_4 8 Tf
119.868 51 Td
(Personal, non-commercial use only. The Journal of Rheumatology. Copyri\
ght \251 2004. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_5 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 29, 2024 from )Tj
ET
endstream
endobj
44 0 obj
<>stream
8;Z\6$'+(##k\-]aEMg9j#W"$Sb/dLg1*ki(c2aS%hicNa,a$=*U#l`Blj!CeK\IVeP@c/>*(1bXIfmWW.
lK$:q*2'#^"t;)'G=csX2:#_Ef/rbGR5>PZPrJ$!"@plId9fmOQ:3=/]J5dLbB3kY
`sh)l^i^pA%`!Eb>dT74[X;mR']u)lV)gB_kT]\DFqn(&2+Uag5RT(W>&T5`!ZMp%
B<>klWX:nFd?i"-\>Ug%W3b*\9?4-!6fEqu1@,?A+g=gKpI[u94sT,MGYa*#nk<"r
*hZ\M*t""^Xq3d!!-(AMoEK=J[uu%7an9B@k@rEQSRu]6VR.N?`dM9.2sQn;TnV2,
&aKjP6>KsHD[pt-XCc9[4@^\<5E*2qo3"
rT+@?!/%1L]Unf5[qT?X[mG#4\25t50_Q>`_qWg#/GY?N&(N=tEX?>:#n7#)]@Dt,
HUSp:TH3]'FU(1u/:L8Bre,Q_(3cV@`_!?Ea[(0VQC'B5Yck9Ln!e.cd-M6Gp(f]tMfK*NDr/Yp9kN&!cT:F&B
4lB'ap]T'!b.Anc=U`7.=jqH@s+k`,/Kq@@j1X]YuOWO
&?*>3`uD>eD8m\olMi
endstream
endobj
48 0 obj
[/Indexed/DeviceRGB 255 47 0 R]
endobj
47 0 obj
<>stream
J,g]g+e/h_!_gCtO=0f)$P%cIi8Zdfc5&3j_8$7g.@L`YKUJNGBP\poR=_;Dl'P(T
(7Boo^^S:71(MN]ZQX/+Cbu.lK"p74pe1T%s.DY%&\1TdJhr54.M9au6>79n6`Q:4
PbLSZTLEE(8E@'*1mg_*eTnN*;*'V3+gm-EEetX%;Bo$ur2ss*N`.-!.kG_q6GDD'
dKoL!8Ka#EV,@V!\j8ZFbp6EE<9cn=N6j0nf;(&;QU6bUD')c@\
9-d\DA=cZ0Q>gIM$$;cd2O@&a;X,Nn_aP(]I1aRc(K1^ue>
gF/(+GaKo$qneLWDrQ#;5\S(\$q'4Q,85`-8;S(=Z"WSBOV*FM)4,?B],R
endstream
endobj
121 0 obj
<>
endobj
72 0 obj
<>
endobj
22 0 obj
<>
endobj
67 0 obj
<>
endobj
104 0 obj
<>
endobj
152 0 obj
<>
endobj
68 0 obj
<>
endobj
95 0 obj
<>stream
H{PSWrE!"/UVuU\DT"H!J$@@@$ @( *o))*Knuv̨驪ngw~937p/0pm(_&?e]0gnm.*lqʜur@ېg[w/{6.m1ǩ3罼6zzyD$ &w-{7[ 8sP&b&0%^(Jb%Oّ̼3"'0eޘዙXF"M bEL?E(ؔ
B7~p,qYgy&ŰO)l/nF`$揕cC%~o15N8UĘy4iC[l@9SK,kq/,&,Zk-ۻ%}KW-f揶vv,trY,eONNFgp(EqZv"i%M f;Oi}VB-+Fxb(Oqu8nj\IkeYǚt@V!K(17'Ouvx杁gaS;220ǿ}EC'\i>_2,hTT%e)e9qzYI8S%Rd"΅+п4ɛh>]ooOB7nli0ґ[ 4a)!>xK߀04zMj'Cn;Պk>~I<P/SU?mW`9[3zf❀ٸ.jDxdEPuiժJrr"e'vE\tiĩUүop,z-#$.(>wor:{Y{/9"+Y\}XS^;tN8CL~C_:ʁ*g` e8>! }I766ϔf0ʠdy^\qT])"f-gGJd|=rhPQ$ɫ8ZۻVoxEY>sݪab`=ͤ\V:C%sO>\a (t!FHba6=iTye[䏡ih?xNE:^+)UYUY]j(?`+玐X/A҈~hj:_Ŗq]eǻ˻;:1A~ 8}jYYb9j-c;Nѭ+sp/9\Xs6;ap?{,JnJ7vb1Z^";ښ.~Er%y]:InAѵŶ4xN)oؽF{:Iݰ0C~q`@h~x8eWw;Vܻ{]*qR֙p%U7T??4CٽG~!F
FS=!?f'K%] :H"Nqr?y}p?q$ل#Dn&`֗e&F_[}r EE!ECm8r@k$R3=zzg/=V/9\?:&̓f/'h+(` ?V+p|t@lo
F2K
4Fk -ԊDui*E!nZ~^zvzIycG.{ RTW OX~ShjwWUkpE?9V
P*ȄEy!7
%H] Dtۃvwh'Z=?G#`TD:V,-ɨ̩+J96EqAczIXGC/qbFfB]"R|IH4UdFf,fPb_ȃ@:sީ:&jr 1eê(;r_(#d'&N`v3.wF5i+.vRS!܃8ޘ$QL,`*VVɃGJ!_b E*VѪnXV2?ڲfs;ywʒC eY.ېuAZl9hVW_іKoط&wd|".o(Z-Tɜ;eK5^E\ʭU EJ.d
}UdU$?#hegρm50yE%XMP:e`
7!bXZ/S_K_zƵU*>
jj%69.%>ZU[jv&8dH!`awz_6?{?F!K`D;7#*%?ib`ikHXA0o|ʦP߃F+5C$;*@ۥMh6n52gR|ͩ(bG%X\JxG>1ڎ]=^pGγbD#/c`uaL:4+Ju9*FG!yŢEW|p>26/q#6`3Ԙy3!b!&kriύLB!fV4,~gl&%36Sfm'mi7JACuîTiF\Z(>D~=,yZP}5ٔD=%yj*fzgY>dʲ+"dIm8k9P\WW^1QAV;`)F:P}]GC(\3dSZz͌b-f_/Z~,>IC\V֨^ @
JV FAO0OOnբ4\;*+ll`Me20
Z+"هգejm41&O~`C7ߊX9hAgW>wu§`R1|Bp_sO8=~ GTSa
O>jz>:&Uow~xX
洭C<gʄ
|Bٚߓ_>S0*ϵF0N8~۟݇`x_˄w=I$Ĕ_-wjc^{- ~ ^"MtS I%%+{qQ{oY۸aX\A|#Öq}ޔL((P&}ǭ(Nn64P_N?r937}Xӛ5{%w1cZ$3K(rÍwZjy0EɈ픤_MDC
,|ja=wN \Eyri55<43'[NvL+NDB`Ko!QL yM;a3fc=yjGz_$&m齱LLju 2ܥ^b:]g86}N}dv$:~[>_D/BUo<31FzW(} 'ڋoHMݏY'A"tm15|wRy
B˓s{hUB)JO-H `:$J=3KaXsM(UBANP:AȠ˄I<'Z{ o9O>Г5\`<3|ƗG[%Qr%Txipy=[S=İWնv6wwPͣ&j0[nr''-'Z!0ǘ!'GI$:UYΨ*h*$"RHF(m[\vW`g)V-媢bc#l+ 9x*X'kJ~LO"*e`I'
kmN27{';z#V{|}Yg6W6$%E/r^
ɰa>0`ս_QʡeQ\(
ya&%%bKmW&SRqu}eLOyY{Bc)fi0o鲔UՖ
Jd@3^AMy!p7nBfe.[-Gumw:U#y